Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Konstantinos Mintzas"'
Autor:
Walter Fiedler, Maximilian Brandes, Bennet Heida, Arnold Kloos, Piroska Klement, Hartmut Döhner, Anuhar Chaturvedi, Felicitas Thol, Katrin Teich, Verena I. Gaidzik, Martin Wichmann, Michael Heuser, Lars Bullinger, Jürgen Krauter, Konstantin Büttner, Arnold Ganser, Carolin Funke, Blerina Neziri, Alessandro Liebich, Clara Wienecke, Konstantinos Mintzas, Michael Stadler, Konstanze Döhner, Albert Heim, Wolfram Puppe, Lothar Hambach, Razif Gabdoulline, Peter Paschka
Publikováno v:
Blood Adv
Next-generation sequencing (NGS)-based measurable residual disease (MRD) monitoring in patients with acute myeloid leukemia (AML) is widely applicable and prognostic prior to allogeneic hematopoietic cell transplantation (alloHCT). We evaluated the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f2231bac9f34e3e8e0522de7a38103a
http://edoc.mdc-berlin.de/20233/7/20233suppl.zip
http://edoc.mdc-berlin.de/20233/7/20233suppl.zip
Autor:
Arnold Ganser, Lina Winckler, Axel Schambach, Felicitas Thol, Adrian Schwarzer, Charu Gupta, Konstantinos Mintzas, Nidhi Jyotsana, Suzan Imren, R. Keith Humphries, Nadine Kattre, Arnold Kloos, Michael Heuser, Felix F. Adams, Razif Gabdoulline, Renate Schottmann, Dirk Heckl, Michaela Scherr, Yasmine Alwie
Publikováno v:
Leukemia
To establish novel and effective treatment combinations for chronic myelomonocytic leukemia (CMML) preclinically, we hypothesized that supplementation of CMML cells with the human oncogene Meningioma 1 (MN1) promotes expansion and serial transplantab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16a9571a188903a9ff1396c3f5f7cc22
Autor:
Maria Xilouri, Panayotis Verginis, Konstantinos Mintzas, Aggelos Banos, Helen Gogas, Ben Wielockx, Sundary Sormendi, Aikaterini Hatzioannou, Themis Alissafi, Alexandros Polyzos, Roza Maria Barouni
Publikováno v:
Journal of Clinical Investigation. 128:3840-3852
Myeloid-derived suppressor cells (MDSCs) densely accumulate into tumors and potently suppress antitumor immune responses, promoting tumor development. Targeting MDSCs in tumor immunotherapy has been hampered by lack of understanding of the molecular
Autor:
Arnold Kloos, Konstantinos Mintzas, Lina Winckler, Razif Gabdoulline, Yasmine Alwie, Nidhi Jyotsana, Nadine Kattre, Renate Schottmann, Michaela Scherr, Charu Gupta, Felix F. Adams, Adrian Schwarzer, Dirk Heckl, Axel Schambach, Suzan Imren, R. Keith Humphries, Arnold Ganser, Felicitas Thol, Michael Heuser
Publikováno v:
Leukemia. 35:3629-3629
Autor:
Konstantinos Mintzas, Michael Heuser
Publikováno v:
Expert opinion on therapeutic targets. 23(6)
Mutations in cohesin genes have been described in numerous solid cancers and hematologic malignancies; subsequent experimental evidence has linked these mutations with carcinogenesis. Areas covered: In this review, we present current information abou
Autor:
Panayotis Verginis, Garyfalia Papadaki, Marianna Ioannou, Konstantinos Mintzas, Prodromos Sidiropoulos, Dimitrios T. Boumpas, George Bertsias, K. Vlachou, Maria Glymenaki
Publikováno v:
Arthritis & Rheumatology. 68:449-461
Objective Emerging evidence supports a crucial role of myeloid-derived suppressor cells (MDSCs) in the regulation of autoimmune diseases. However, their role in systemic lupus erythematosus (SLE) remains unknown. This study sought to address the role
Autor:
Simon Danisch, Renata Stripecke, Felicitas Thol, Michael Heuser, Arnold Kloos, Razif Gabdoulline, Renate Schottmann, Konstantinos Mintzas, Arnold Ganser
Publikováno v:
Blood. 132:3933-3933
INTRODUCTION On average 5 recurrent mutations are present in each patient with acute myeloid leukemia (AML). Many mutated genes are implicated as tumor suppressor genes, but their contribution to leukemia stem cell (LSC) survival and chemoresistance
Autor:
Katerina, Vlachou, Konstantinos, Mintzas, Maria, Glymenaki, Marianna, Ioannou, Garyfalia, Papadaki, George K, Bertsias, Prodromos, Sidiropoulos, Dimitrios T, Boumpas, Panayotis, Verginis
Publikováno v:
Arthritisrheumatology (Hoboken, N.J.). 68(2)
Emerging evidence supports a crucial role of myeloid-derived suppressor cells (MDSCs) in the regulation of autoimmune diseases. However, their role in systemic lupus erythematosus (SLE) remains unknown. This study sought to address the role of MDSCs